GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemCell Institute (TSE:7096) » Definitions » Other Income (Minority Interest)

StemCell Institute (TSE:7096) Other Income (Minority Interest) : 円0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is StemCell Institute Other Income (Minority Interest)?

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary. StemCell Institute's Other Income (Minority Interest) for the three months ended in Sep. 2024 was 円0 Mil. Its Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Sep. 2024 was 円0 Mil.


StemCell Institute Other Income (Minority Interest) Historical Data

The historical data trend for StemCell Institute's Other Income (Minority Interest) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemCell Institute Other Income (Minority Interest) Chart

StemCell Institute Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Income (Minority Interest)
Get a 7-Day Free Trial - - - - -

StemCell Institute Quarterly Data
Mar18 Mar19 Dec19 Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Other Income (Minority Interest) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

StemCell Institute Other Income (Minority Interest) Calculation

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary.

Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


StemCell Institute  (TSE:7096) Other Income (Minority Interest) Explanation

Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company. It is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


StemCell Institute Business Description

Industry
Traded in Other Exchanges
N/A
Address
Shimbashi, Minato-ku, Tamuracho Building, Matsuoka, Tokyo, JPN, 105-0004
StemCell Institute is engaged in Cell bank business that separates and stores cord blood for regenerative medicine. Cord blood is the baby's blood contained in the umbilical cord and placenta that connects mother and baby. In its umbilical cord blood storage business, upon receiving notification from customers who have contracted, umbilical cord blood collected at obstetric facilities throughout Japan is collected, transported to the company's own cell processing center within 48 hours, and it provides a service to store cells at ultra-low temperature after separating cells from blood.

StemCell Institute Headlines

No Headlines